ORION OYJ -  

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 3
As coordinator: 0
As participant: 3
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 0 7.573.014 0 1
2019 0 20.997.523 0 1
2018 0 6.000.000 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE2
JANSSEN PHARMACEUTICA NV2
SANOFIAVENTIS2
ABBVIE INC1
ASOCIACION PARKINSON MADRID1
ASSOCIATION EISBM1
ASTELLAS PHARMA EUROPE BV1
ASTRAZENECA1
BAYER1
BENKEI1
BIOGEN IDEC LIMITED1
BYTEFLIES1
CAMBRIDGE COGNITION LIMITED1
CANCER INTELLIGENCE LIMITED1
CIRCA GROUP AS1
COVANCE LABORATORIES1
DREEM1
DRESDEN UNIVERSITY OF TECHNOLOGY1
ECOLOGIC INSTITUT GEMEINNUETZIGE1
ECRIN EUROPEAN CLINICAL RESEARCH INFRASTRUCTURE NETWORK1
ELI LILLY AND COMPANY LIMITED1
EMPIRICA GESELLSCHAFT FUR KOMMUNIKATIONS UND TECHNOLOGIEFORSCHUNG MBH1
EUROPEAN ALLIANCE FOR PERSONALISED MEDICINE ASBL1
EUROPEAN CANCER PATIENT COALITION1
EUROPEAN FEDERATION OF CROHN'S AND ULCERATIVE COLITIS ASSOCIATIONS1
EUROPEAN ORGANISATION FOR RESEARCH AND TREATMENT OF CANCER AISBL1
F HOFFMANNLA ROCHE1
FCIENCIASID ASSOCIACAO PARA A INVESTIGACAO E DESENVOLVIMENTO DE CIENCIAS1
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V1
GEORGEHUNTINGTONINSTITUT1
GOETEBORGS UNIVERSITET1
GROUPE DES ECOLES DES TELECOMMUNICATIONS1
HELSE STAVANGER HF1
IHE INSTITUTET FOR HALSO OCH SJUKVARDSEKONOMI AKTIEBOLAG1
IMS INFORMATION SOLUTIONS MEDICAL RESEARCH LIMITED1
INSTITUTE OF PSYCHIATRY AND NEUROLOGY1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
INTERNATIONAL CONSORTIUM FOR HEALTHOUTCOMES MEASUREMENT1
IXSCIENT LIMITED1
KELADA PHARMACHEM LIMITED1
KING'S COLLEGE LONDON1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LEUPHANA UNIVERSITAT LUNEBURG1
LIXOFT SAS1
LUND UNIVERSITY1
MCROBERTS BV1
MEDIBIOSENSE1
MEDIZINISCHE UNIVERSITAT INNSBRUCK1
NV SAS INSTITUTE1
PARKINSON'S DISEASE SOCIETY OF THEUNITED KINGDOM LBG1
PFIZER LIMITED1
PINSENT MASONS LLP1
PLURIBUS ONE1
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
STICHTING EUROPEAN UROLOGICAL FOUNDATION1
STICHTING KATHOLIEKE UNIVERSITEIT1
STICHTING MLC FOUNDATION1
STICHTING RADBOUD UNIVERSITEIT1
TAKEDA DEVELOPMENT CENTRE EUROPE1
TAKEDA PHARMACEUTICALS INTERNATIONAL1
THE ECANCER GLOBAL FOUNDATION1
THE HYVE BV1
THE UNIVERSITY OF MANCHESTER1
TMF TECHNOLOGIE UND METHODENPLATTFORM FUR DIE VERNETZTE MEDIZINISCHE FORSCHUNG EV1
TTOPSTART BV1
UCB BIOPHARMA1
UNIVERSIDAD AUTONOMA DE MADRID1
UNIVERSITA DEGLI STUDI DI BRESCIA1
UNIVERSITA VITASALUTE SAN RAFFAELE1
UNIVERSITAETSKLINIKUM HAMBURGEPPENDORF1
UNIVERSITATSKLINIKUM SCHLESWIGHOLSTEIN1
UNIVERSITEIT GENT1
UNIVERSITY OF ABERDEEN1
UNIVERSITY OF CAMBRIDGE1
UNIVERSITY OF GLASGOW1
UNIVERSITY OF HELSINKI1
UNIVERSITY OF LIMERICK1
UNIVERSITY OF NEWCASTLE UPON TYNE1
UNIVERSITY OF TAMPERE1
UNIVERSITY OF YORK1
VARIAN MEDICAL SYSTEM DEUTSCHLAND1
VTT TECHNICAL RESEARCH CENTRE OF FINLAND1
WEIZMANN INSTITUTE OF SCIENCE1

Constancy:

Total number of partners: 89
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 89
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2022-06-01Transforming into a sustainable European pharmaceutical sector TransPharmparticipant7.573.01411
2019-11-01Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases IDEA-FASTparticipant20.997.52347
2018-05-01Prostate Cancer DIagnOsis and TreatmeNt Enhancement through the Power of Big Data in EuRope PIONEERparticipant6.000.00034